Living With Sickle Cell Disease in the COVID-19 Pandemic | MicrobiomeTrials← Back to trialsNCT04417673
Living With Sickle Cell Disease in the COVID-19 Pandemic
CompletedOBSERVATIONAL
Trial Details
Start: 2020-06-15Est. Completion: 2022-05-18
Enrollment target: 186 participants Locations- National Human Genome Research Institute (NHGRI), Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Polypathology
For several decades, there is an aging population, particularly in industrialized countries. This lengthening of the dur…
Limoges, FranceCompleted Jan 2018
Solid TumorHealthyMalignant Solid Neoplasm
The purpose of this study is to understand how the body's immune cells respond to a new type of vaccine (neoantigen vacc…
Jacksonville, United StatesEst. completion Oct 31, 2028